NNY vs OXSQ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NNY exhibits a weak deterministic health profile with a Piotroski F-Score of 3/9, indicating poor fundamental momentum. However, as a municipal value fund, its valuation is best viewed through its Price-to-Book ratio of 1.00, suggesting it is trading exactly at its net asset value. While profitability metrics are negative and technical trends are bearish (0/100), the fund maintains a stable dividend yield of 4.14% and positive long-term price appreciation. The overall outlook is neutral, as the fund serves as an income vehicle rather than a growth equity.
OXSQ exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. The company's dividend profile is unsustainable, with a payout ratio of 466.67% and a yield of 22.46% that likely erodes capital. Negative profit margins (-46.43%) and a bearish technical trend (0/100) further underscore a deteriorating operational state. With a target price of $1.75 sitting below the current market price, there is little fundamental support for current valuation levels.
Compare Another Pair
Related Comparisons
NNY vs OXSQ: Head-to-Head Comparison
This page compares Nuveen New York Municipal Value Fund (NNY) and Oxford Square Capital Corp. (OXSQ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.